Health & Environmental Research Online (HERO)


Print Feedback Export to File
3859701 
Journal Article 
Tissue toxicokinetics of perfluoro compounds with single and chronic low doses in male rats 
Iwabuchi, K; Senzaki, N; Mazawa, D; Sato, I; Hara, M; Ueda, F; Liu, W; Tsuda, S 
2017 
Yes 
Journal of Toxicological Sciences
ISSN: 0388-1350
EISSN: 1880-3989 
42 
301-317 
English 
To examine the kinetics of low doses of perfluoro compounds (PFCs), we administered perfluorohexanoic acid (C6A), perfluorooctanoic acid (C8A), perfluorononanoic acid (C9A) and perfluorooctane sulfonate (C8S) with a single oral dose (50-100 μg/kg BW), and in drinking water at 1, 5, and 25 μg/L for one and three months to male rats; and examined the distribution in the brain, heart, liver, spleen, kidney, whole blood and serum. C6A was very rapidly absorbed, distributed and eliminated from the tissues with nearly the same tissue t1/2 of 2-3 hr. Considering serum Vd, and the tissue delivery, C6A was mainly in the serum with the lowest delivery to the brain; and no tissue accumulation was observed in the chronic studies as estimated from the single dose study. For the other PFCs, the body seemed to be an assortment of independent one-compartments with a longer elimination t1/2 for the liver than the serum. The concentration ratio of liver/serum increased gradually from C0 to a steady state. The high binding capacity of plasma protein may be the reason for the unusual kinetics, with only a very small fraction of free PFCs moving gradually to the liver. Although the tissue specific distribution was time dependent and different among the PFCs, the Vd and ke of each tissue were constant throughout the study. The possibility of extremely high C6A accumulation in the human brain and liver was suggested, by comparing the steady state tissue concentration of this study with the human data reported by Pérez et al. (2013). 
Perfluoro compounds; Perfluorohexanoic acid; Tissue specific distribution; Human tissue accumulation 
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
               WOS
     PFNA (375-95-1)
          Literature Search
               Pubmed
               WOS
     PFHxA (307-24-4)
          Literature Search
               Pubmed
• PFHxA
     Literature Search
          Pubmed
     Literature Search: February 2018 Update
          Toxline
          WoS
     Screening Results
          Toxicokinetic studies
               ADME
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               ADME
     Literature Search
          Pubmed
          WOS
          Toxline
• PFNA
     Literature Search
          Pubmed
          Toxline
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
     PFNA Literature Search pre-2019
          Pubmed
          WOS
     PFNA May 2019 Update
          Pubmed
          Toxnet
          Web of Science
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               ADME
               Mixture-only
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
     Literature Search Update (2013-2019)
          PubMed
          WOS